Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
5.13
-0.44 (-7.82%)
At close: Nov 19, 2026, 4:00 PM EST
5.15
+0.02 (0.39%)
After-hours: Nov 19, 2026, 4:36 PM EST
Cytosorbents Stock Forecast
CTSO's stock price has decreased by -58.73% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 2 analysts polled by S&P Global, Cytosorbents stock has an average price target of $32.5. The average 1-year stock price forecast is 533.53% higher than the current stock price, while the lowest is $15 (+192.40%) and the highest is $50 (+874.66%).
Price Target: $32.5 (+533.53%)
Analyst Consensus: n/a
Price Target
ChartAnalyst Ratings
According to 1 stock analyst, the rating for Cytosorbents is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Aug '26 | Sep '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| WBB Securities | WBB Securities | Buy Initiates $9.5 | Buy | Initiates | $9.5 | +85.19% | Oct 21, 2026 |
| H.C. Wainwright | H.C. Wainwright | Hold Maintains $15 | Hold | Maintains | $15 | +192.40% | Aug 7, 2026 |
Financial Forecast
Revenue This Year
37.86M
from 37.06M
Increased by 2.14%
Revenue Next Year
44.00M
from 37.86M
Increased by 16.24%
EPS This Year
0.40
EPS Next Year
-0.40
from 0.40
EPS and Forward PE are based on non-GAAP adjusted numbers.